Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report

SM Stevens, SC Woller, LB Kreuziger, H Bounameaux… - Chest, 2021 - Elsevier
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis

SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Position paper on the management of pregnancy-associated superficial venous thrombosis. Balkan working group for prevention and treatment of venous …

D Antic, E Lefkou, V Otasevic, L Banfic… - Clinical and Applied …, 2022 - journals.sagepub.com
Venous thromboembolism (VTE) is a multifactorial disease that can possibly affect any part
of venous circulation. The risk of VTE increases by about 2 fold in pregnant women and VTE …

Predictive factors of clot propagation in patients with superficial venous thrombosis towards deep venous thrombosis and pulmonary embolism: a systematic review …

FSA van Royen, M van Smeden, S van Doorn… - BMJ open, 2024 - bmjopen.bmj.com
Objective A subset of patients with superficial venous thrombosis (SVT) experiences clot
propagation towards deep venous thrombosis (DVT) and/or pulmonary embolism (PE). The …

[HTML][HTML] The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management …

P Gloviczki, PF Lawrence, SM Wasan… - Journal of Vascular …, 2024 - Elsevier
Abstract The Society for Vascular Surgery, the American Venous Forum, and the American
Vein and Lymphatic Society recently published Part I of the 2022 clinical practice guidelines …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases

CP Twine, SK Kakkos, V Aboyans… - European Journal of …, 2023 - Elsevier
1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Risk factors of deep vein thrombosis of lower extremity in patients undergone gynecological laparoscopic surgery: what should we care

Q Tian, M Li - BMC Women's Health, 2021 - Springer
Background Deep vein thrombosis (DVT) significantly influences the prognosis of patients.
It's necessary to analyze the risk factors for postoperative DVT in patients undergone …

Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021

SM Stevens, SC Woller, LB Kreuziger, K Doerschug… - Chest, 2024 - Elsevier
Abstract BACKGROUND The CHEST Antithrombotic Therapy for Venous Thromboembolism
Disease evidencebased guidelines are now updated in a more frequent, focused manner …

A multicenter, randomized, dose-finding study of mechanochemical ablation using ClariVein and liquid polidocanol for great saphenous vein incompetence

YL Lam, T Alozai, MA Schreve, AAEA de Smet… - Journal of Vascular …, 2022 - Elsevier
Background The purpose of the present study was to identify the ideal polidocanol (POL)
concentration for mechanochemical ablation (MOCA) of the great saphenous vein (GSV) …

[HTML][HTML] A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients …

K Lobastov, E Dubar, I Schastlivtsev… - Journal of Vascular …, 2023 - Elsevier
Objective To determine the association between the duration of systemic anticoagulation
therapy (ACT) and the risk of further venous thromboembolism (VTE) in patients with …